Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
While highly effective, this medication can cause gastrointestinal side effects due to its mechanism of slowing gastric emptying
As more individuals grapple with obesity and its associated health risks, this medication offers a beacon of hope, appealing to both healthcare providers and patients alike
therefore, the patient must act patiently and protectively
it is banned at all times, in and out of competition, for athletes subject to anti-doping codes, and is not classified under S2 (Peptide Hormones, Growth Factors, and Related Substances), which is reserved for specifically defined peptide hormones and growth factors such as hGH and EPO
Jastreboff AM et al., Phase 2 retatrutide, NEJM 2023 (NEJMoa2301972, PMID 37366315) -24,2% at 48 weeks at the 12 mg level
US$ 29.76
US$ 27.50
US$ 23.39
US$ 25.65
US$ 25.78
US$ 24.93
